Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PD P 506 A PDT for Distal Subungual Onychomycosis
NCT02355899Phase 2Completed
- Sponsor
- photonamic GmbH & Co. KG
- Start
- Jan 2015
- Primary completion
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of 5-aminolevulinic acid in onychomycosis, sponsored by photonamic GmbH & Co. KG. Primary endpoint: Percentage of nails with Clinically Complete Cure at 12 months. Started Jan 2015; status: completed.
02
Drugs
5-aminolevulinic acid
03
Conditions
onychomycosis
Beyond the preview
Go deeper on NCT02355899.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02355899.